Skip to main content

Table 2 Surveillance drug resistance mutations patterns for patients

From: Local phylogenetic analysis identifies distinct trends in transmitted HIV drug resistance: implications for public health interventions

  TDR Mutations  
Patient NRTI NNRTI PI
1 D67N, K219Q   
2 D67N, K219Q   
3 K65KR, D67N, K219Q   
4   K103N  
5 D67N, K219Q   
6 D67N, K219Q   M46LM
7 D67N, K219Q   
8 D67N, K219Q   
9 D67N, K219Q   
10 T215C K103N  
11 D67N, K70R, M184V, T215F, K219E K103N L90M
12 D67N, K219Q   
13 K70R   
14 D67N, K219Q   
15 D67N, K219Q   
16 D67N, K219Q   
17 D67N, K219Q   
18 D67N, K219Q   
19 D67N, K219Q   
  1. Prevalence of each TDR mutation among the 155 specimens were: D67N (10.3%), K219Q (9.7%), K103N (1.9%), K70R (1.3%), with all others at 0.6%.